Publicaciones (23) Publicaciones en las que ha participado algún/a investigador/a

2013

  1. A cross-sectional study of the association between circulating TSH level and lipid profile in a large Spanish population

    Clinical Endocrinology, Vol. 79, Núm. 6, pp. 874-881

  2. A role for adipocyte-derived lipopolysaccharide-binding protein in inflammation- and obesity-associated adipose tissue dysfunction

    Diabetologia, Vol. 56, Núm. 11, pp. 2524-2537

  3. Adipose tissue immunity and cancer

    Frontiers in Physiology, Vol. 4 OCT

  4. Análisis sobre los motivos de derivación de pacientes con diabetes mellitus tipo 2 entre atención primaria y atención especializada. Estudio Pathways

    Avances en Diabetologia, Vol. 29, Núm. 3, pp. 60-67

  5. Cardiotrophin 1 protects beta cells from apoptosis and prevents streptozotocin-induced diabetes in a mouse model

    Diabetologia, Vol. 56, Núm. 4, pp. 838-846

  6. Co-occurrence of non-suicidal self-injury and impulsivity in extreme weight conditions

    Personality and Individual Differences, Vol. 54, Núm. 1, pp. 137-140

  7. Evaluación y manejo de la hipoglucemia en el paciente con diabetes mellitus. Documento de posicionamiento: grupo de Trabajo de Diabetes Mellitus de la Sociedad Española de Endocrinología y Nutrición

    Endocrinología y nutrición: órgano de la Sociedad Española de Endocrinología y Nutrición, Vol. 60, Núm. 9, pp. 1101-1118

  8. Increased levels of chemerin and its receptor, chemokine-like receptor-1, in obesity are related to inflammation: Tumor necrosis factor-α stimulates mRNA levels of chemerin in visceral adipocytes from obese patients

    Surgery for Obesity and Related Diseases, Vol. 9, Núm. 2, pp. 306-314

  9. Interdisciplinary European guidelines on metabolic and bariatric surgery

    Obesity Facts, Vol. 6, Núm. 5, pp. 449-468

  10. Iron and Obesity Status-Associated Insulin Resistance Influence Circulating Fibroblast-Growth Factor-23 Concentrations

    PLoS ONE, Vol. 8, Núm. 3

  11. Liver glycerol permeability and aquaporin-9 are dysregulated in a murine model of non-alcoholic fatty liver disease

    PLoS ONE, Vol. 8, Núm. 10

  12. Liver, but not adipose tissue PEDF gene expression is associated with insulin resistance

    International Journal of Obesity, Vol. 37, Núm. 9, pp. 1230-1237

  13. Modulation of the Endocannabinoids N-Arachidonoylethanolamine (AEA) and 2-Arachidonoylglycerol (2-AG) on Executive Functions in Humans

    PLoS ONE, Vol. 8, Núm. 6

  14. Obesity: The gateway to ill health - An EASO position statement on a rising public health, clinical and scientific challenge in Europe

    Obesity Facts, Vol. 6, Núm. 2, pp. 117-120

  15. Obeso metabólicamente sano: ¿mito o realidad?

    Revista de nutrición práctica, Año 17, pp. 10-10

  16. Obstructive sleep apnea severity is associated with left ventricular mass independent of other cardiovascular risk factors in morbid obesity

    Journal of Clinical Sleep Medicine, Vol. 9, Núm. 11, pp. 1165-1171

  17. Role of PRDM16 in the activation of brown fat programming. Relevance to the development of obesity

    Histology and Histopathology, Vol. 28, Núm. 11, pp. 1411-1425

  18. Six-transmembrane epithelial antigen of prostate 4 and neutrophil gelatinase-associated lipocalin expression in visceral adipose tissue is related to iron status and inflammation in human obesity

    European Journal of Nutrition, Vol. 52, Núm. 6, pp. 1587-1595

  19. Targeting the association of calgranulin B (S100A9) with insulin resistance and type 2 diabetes

    Journal of Molecular Medicine, Vol. 91, Núm. 4, pp. 523-534

  20. Targeting the circulating microRNA signature of obesity

    Clinical Chemistry, Vol. 59, Núm. 5, pp. 781-792